Literature DB >> 12534129

Imported viral haemorrhagic fever with a potential for person-to-person transmission: review and recommendations for initial management of a suspected case in Belgium.

R Colebunders1, M Van Esbroeck, M Moreau, M Borchert.   

Abstract

Viral haemorrhagic fevers are caused by a wide range of viruses. There are 4 types of viruses well known to spread from person to person and able to cause nosocomial outbreaks with a high case fatality rate: an arenavirus (Lassa fever and more exceptionally the Junin and Machupo virus), a bunyavirus (Crimean-Congo haemorrhagic fever) and the Filoviridae (Ebola and Marburg viruses). So far there have been only a limited number of imported cases of viral haemorrhagic fever in industrialized countries. In recent years an increasing number of outbreaks of filovirus infections have occurred in Africa and in 2000 5 cases of Lassa fever were brought from Sierra Leone to Europe. Therefore European physicians should consider the possibility of a viral haemorrhagic fever in an acutely ill patient just returning from Africa or South-America with fever for which there is no obvious cause. Such patients should be questioned for risk factors for viral haemorrhagic fever. Using universal precautions for handling blood and body fluids and barrier nursing techniques there is little risk that if a patient with viral haemorrhagic fever arrives in Belgium there will be secondary cases.

Entities:  

Mesh:

Year:  2002        PMID: 12534129     DOI: 10.1179/acb.2002.047

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  5 in total

1.  Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report.

Authors:  Luis M Branco; Matt L Boisen; Kristian G Andersen; Jessica N Grove; Lina M Moses; Ivana J Muncy; Lee A Henderson; John S Schieffellin; James E Robinson; James J Bangura; Donald S Grant; Vanessa N Raabe; Mbalu Fonnie; Eleina M Zaitsev; Pardis C Sabeti; Robert F Garry
Journal:  Virol J       Date:  2011-08-15       Impact factor: 4.099

2.  Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report.

Authors:  Jessica N Grove; Luis M Branco; Matt L Boisen; Ivana J Muncy; Lee A Henderson; John S Schieffellin; James E Robinson; James J Bangura; Mbalu Fonnie; Randal J Schoepp; Lisa E Hensley; Alhassan Seisay; Joseph N Fair; Robert F Garry
Journal:  Virol J       Date:  2011-06-20       Impact factor: 4.099

3.  Crimean-Congo hemorrhagic fever in Turkey.

Authors:  S Sami Karti; Zekaver Odabasi; Volkan Korten; Mustafa Yilmaz; Mehmet Sonmez; Rahmet Caylan; Elif Akdogan; Necmi Eren; Iftihar Koksal; Ercument Ovali; Bobbie R Erickson; Martin J Vincent; Stuart T Nichol; James A Comer; Pierre E Rollin; Thomas G Ksiazek
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883

4.  The basic principles of migration health: population mobility and gaps in disease prevalence.

Authors:  Brian D Gushulak; Douglas W MacPherson
Journal:  Emerg Themes Epidemiol       Date:  2006-05-04

5.  Diagnostic proficiency and reporting of Lassa fever by physicians in Osun State of Nigeria.

Authors:  Samuel Anu Olowookere; Akinola Ayoola Fatiregun; Olalere Omoyosola Gbolahan; Ebenezer Gbenga Adepoju
Journal:  BMC Infect Dis       Date:  2014-06-20       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.